www.rupeedesk.in
Most pharmaceutical stocks touched their lifetime highs this week, and are likely to continue the upward trend. It can be a consolidation time. Sector is outperforming. Many (pharma) stocks have touched lifetime high. It will continue. Today, Dr Reddys Laboratories Ltd shares closed at 2,412.20 rupees on the National Stock Exchange. Kyal said that he believes the stock of the Hyderabad-based company will continue to
outperform. We expect Dr Reddy's stock prices to grow in the light of limited competition in some of its products categories. Sun Pharmaceuticals Ltd is seen positive as its US business is likely to do well with products such as Doxil. For Wockhardt Ltd, Bothra said the company's receiving a Form 483, which highlights deviations in manufacturing processes, from the US Food and Drug Administration raises some concerns. "That would pose viability issues for the company.
Most pharmaceutical stocks touched their lifetime highs this week, and are likely to continue the upward trend. It can be a consolidation time. Sector is outperforming. Many (pharma) stocks have touched lifetime high. It will continue. Today, Dr Reddys Laboratories Ltd shares closed at 2,412.20 rupees on the National Stock Exchange. Kyal said that he believes the stock of the Hyderabad-based company will continue to
outperform. We expect Dr Reddy's stock prices to grow in the light of limited competition in some of its products categories. Sun Pharmaceuticals Ltd is seen positive as its US business is likely to do well with products such as Doxil. For Wockhardt Ltd, Bothra said the company's receiving a Form 483, which highlights deviations in manufacturing processes, from the US Food and Drug Administration raises some concerns. "That would pose viability issues for the company.
